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Purpose: This study aimed to determine the value of the NTrap
Ⓡ (Cook Urological INC, 
USA), which was designed to block the upward movement of stones during uretero-
scopic lithotripsy. 
Materials and Methods: We reviewed the data of 144 patients who underwent uretero-
scopic lithotripsy for an upper ureteral stone from June 2006 to May 2010. Sixty-eight 
patients who underwent ureteroscopic lithotripsy without the use of the NTrap
Ⓡ were 
assigned to Group I and 76 patients who underwent ureteroscopic lithotripsy with the 
NTrap
Ⓡ were assigned to Group II. The size of the stones, operation time, success rate, 
and pre- and postoperative complications were compared retrospectively between the 
two groups. 
Results: The mean age of the patients (Group I: 35.8 years; Group II: 32.6 years) and 
the sex ratios were not significantly different between the two groups. The mean size 
of the stones was 6.9 mm and 7.4 mm, which also was not significantly different between 
the two groups. The mean operation time was 82.7 minutes and 78.7 minutes. The oper-
ation time was shorter in Group II, but the difference was not significant. The success 
rate of stone removal was 89.7% and 98.7% in Groups I and II, respectively; Group II 
showed a significantly higher success rate. Two cases of ureteral perforation and one 
case of ureteral avulsion occurred in Group I, and one case of ureteral perforation oc-
curred in Group II. 
Conclusions: NTrap
Ⓡ, which is an instrument used to assist during ureteroscopic litho-
tripsy, can be considered to be an effective tool that blocks the upward movement of 
the stone and aids in safe stone removal. 
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In the past, there were limitations in treating ureteral cal-
culi, but extensive developments have been made since the 
introduction of new techniques such as ureteroscopy and 
extracorporeal shock wave lithotripsy (ESWL). Endoscopic 
technology equipped with advanced intracorporeal litho-
tripsy enables the treatment of calculi of the upper urinary 
tract [1]. 
Indeed, in addition to small-diameter ureteroscopes, the 
newly developed techniques of intracorporeal lithotripsy 
such as ultrasound, electrohydraulic, lithoclast, and more 
recently the holmium:YAG laser make endoscopic removal 
of upper ureteral calculi safer and more successful than it 
had been two decades ago [2-4]. 
However, stone retropulsion during intracorporeal lith-
otripsy occurs in 5% to 40% of cases. The risk of retropulsion 
is influenced by the pressure of the irrigant fluid, type of 
energy source used for intracorporeal lithotripsy, site and 
degree of calculus impaction, and degree of proximal ure-
teral dilation [5]. Smaller stones and greater proximal ure-
teral dilation or hydroureteronephrosis increase the rate 
of retropulsion.
As solutions for this retropulsion, new instruments such Korean J Urol 2010;51:719-723
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as the Accordion
Ⓡ (Percsys, Palo Alto, CA, USA), Stone 
Cone (Boston Scientific, Natick, MA, USA), and NTrap
Ⓡ 
(Cook Urological, Bloomington, IN, USA) have been deve-
loped. The NTrap
Ⓡ is a novel device designed to prevent the 
retropulsion of ureteral stones and enables safe extraction 
of stone fragments during ureteroscopic lithotripsy. We 
present our experience with the use of the NTrap
Ⓡ during 
intracorporeal lithotripsy of upper ureteral stones over a 
4-year period.
MATERIALS AND METHODS 
In this retrospective study, we reviewed the data of 194 pa-
tients who had undergone ureteroscopic stone removal for 
an upper ureteral stone from June 2006 to May 2010 at our 
institution. Data from patients who had undergone open 
surgery and those who had suffered from certain diseases 
such as active urinary tract infection, congenital anoma-
lies, and previous or access failure were excluded. Uretero-
scopic access was successfully achieved for 191 patients 
(98.5%). In 47 patients (24.6%), calculi were retrieved in-
tact by use of a stone basket only, whereas in 144 patients 
(75.4%) lithotripsy was required. Among all subjects, 144 
patients (75.4%) were identified as having undergone ure-
teroscopic lithotripsy. For statistical analysis, subjects 
were divided into Group I and Group II according to the use 
of the NTrap
Ⓡ. Sixty-eight patients who underwent ure-
teroscopic lithotripsy without the use of the NTrap
Ⓡ were 
assigned to Group I, and 76 patients who underwent ure-
teroscopic lithotripsy with the NTrap
Ⓡ were assigned to 
Group II. Additionally, Group II was divided into two sub-
groups according to the type of lithotripter used.
The holmium:YAG laser was used in 117 cases (81.3%). 
In this observation, the holmium:YAG laser provided suc-
cessful fragmentation, disintegrating all types of calculi in-
to very small fragments (less than 2 mm) that could be easi-
ly washed away with irrigation. The Wolf-lithoclast was 
used for 27 patients (18.8%), and the fragmentation was 
successful in all cases. One hundred sixteen (80.6%) pa-
tients had a single calculus, and the other 28 patients 
(19.4%) had more than one calculus. Stone size (maximal 
diameter on KUB or computed tomography) ranged from 
4 to 15 mm.
The size of the stones, operative time, stone-free rate, and 
intraoperative complications in the two groups were inves-
tigated retrospectively. A retrograde ureteroscopic appro-
ach was applied for all patients with a 7.5/8 Fr Storz rigid 
ureteroscope with a 5 Fr working channel. Routine bio-
chemical analysis, blood count, urinalysis, and culture of 
urine were performed preoperatively. Intravenous pyelo-
gram or computed tomography was taken to confirm the di-
agnosis and determine the exact locations and sizes of the 
stones. Prophylactic antibiotics were injected intravenously 
in all patients.
The operation was performed with the patients under 
spinal or general anesthesia in the lithotomy position. 
Introduction of the ureteroscope into the ureter was aided 
by a 0.038 inch floppy-tipped guidewire. The ureteral or-
ifice was dilated only when necessary for placement of the 
ureteroscope. In Group II, under fluoroscopic guidance, the 
NTrap
Ⓡ was opened above the stone by advancing the inner 
wire.
The holmium:YAG laser was most frequently used as a 
lithotripter (81.3%). The 550 μm fiber was used in all cases. 
To initiate stone fragmentation, the laser frequency was 
usually set at a frequency at 6 Hz and the energy pulse at 
0.6 J. The Wolf-lithoclast was the second most commonly 
used lithotripter (18.7%) with a 3.5 mm metal probe. Once 
the stone was visualized, the lithotriptors were introduced 
via the ureteroscope and the stone was fragmented. 
Fragmented stones were removed from the ureter as much 
as possible by using a basket or forceps. After the operation, 
every retrieved stone fragment was qualitatively analyzed 
to verify the chemical composition of each stone. A double 
J stent was placed postoperatively in all patients for an 
average of 1 to 2 weeks.
An operation was regarded as successful when no re-
sidual fragments were larger than 2 mm in size and no addi-
tional procedure was required. Postoperative imaging con-
sisted of abdominal plain radiography or computed tomog-
raphy. A plain radiograph of KUB was performed on the 
first day after the operation, and after a week, another ra-
diograph was taken to examine residual stone fragments. 
Most patients were discharged on the first postoperative 
day. The double J stent was removed after 1 to 2 weeks. All 
operations were conducted by a single surgeon.
Statistical comparison between Group I and Group II 
was done by use of mean±standard deviation, chi-square 
test, and Fisher 2-sided exact test. p＜0.05 was considered 
statistically significant. The SPSS ver. 12.0 (SPSS Inc., 
Chicago, IL, USA), was used for this statistical analysis.
RESULTS 
The characteristics of the 144 patients are shown in Table 
1. No significant differences were observed in age, sex, 
stone diameter, or type of lithotriptor between Group I and 
Group II at the time of surgery.
Two weeks after the operations, the success rate was 
94.4%. The rates of successful removal of the stones were 
89.7% and 98.7% for Group I and Group II, respectively. 
Group II showed a significantly higher success rate than 
did Group I (p=0.019). For stones ≤5 mm size, the success 
rate was 92.3% in Group I and was 100% in Group II, and 
no statistically significant difference was observed be-
tween the two groups. However, for stones ＞5 mm size, 
Group II showed a significantly higher rate of successful 
removal. Group II showed a significantly higher success 
rate with the use of the holmium:YAG laser as the litho-
triptor (Table 2). 
Residual stones larger than 2 mm were noted in 8 cases 
at 2 weeks after surgery. Among these 8 cases, 6 cases were 
caused by retropulsion during lithotripsy, and the other re-
sulted from incidental ureteral perforation during litho-Korean J Urol 2010;51:719-723
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TABLE 1. Baseline patient characteristics 
Group I Group II
p-value 
without using the NTrap
Ⓡ using the NTrap
Ⓡ
No. of cases  68  76 
  Men  50  53  0.618 
  Women  18  23 
Age (yr)  35.8±13.9 (18-73)  32.6±12.3 (18-68)  0.152 
Stone diameter (mm)        6.9±1.83 (4.0-12.0)        7.4±2.03 (4.0-15.0)  0.117 
Lithotriptor 
  Wolf-lithoclast  11  16 
0.458 
  Holmium:YAG laser  57  60 
TABLE 2. Success rate, operative time, and intra-operative complications according to the use of the Ntrap
Group I Group II
                                                                       p-value 
without using the NTrap
Ⓡ using the NTrap
Ⓡ
Overall success rate (%)         89.7 (61/68)         98.7 (75/76)  0.019 
Success rate of stone diameter ≤5 mm (%)         92.3 (13/14)      100 (9/9)  0.412 
Success rate of stone diameter  ＞5 mm (%)         88.9 (48/54)         98.5 (66/67)  0.024 
Success rate of Wolf-lithoclast as lithotriptor (%)         90.1 (10/11)         93.8 (15/16)  0.792 
Success rate of holmium:YAG laser as lithotriptor (%)         89.5 (51/57)          100 (60/60)  0.010 
Operative time  82.6±14.4 (60-120) 78.3±14.6  (50-110) 0.075 
Intraoperative complications 3  1  0.344 
TABLE 3. Failure rate and stone migration rate and treatment of










Failure rate (%) 10.3 (7/68) 1.3 (1/76) 
  Stone migration rate (%)   8.8 (6/68) 0 
Treatment
  ESWL 5 1
  Repeated URS 1 0
  RIRS 1 0
ESWL: extracorporeal shock wave lithotripsy, URS: ureteroscopic
removal of stone, RIRS: retrograde intrarenal surgery
tripsy. Failed patients reached a stone-free state with 
ESWL (6 cases) or repeated ureteroscopic lithotripsy (2 cas-
es; Table 3).
The average durations of the operation in Group I and 
Group II were 82.6±14.4 minutes (range, 60-120 minutes) 
and 78.3±14.6 minutes (range, 50-110 minutes), respecti-
vely. Although Group II showed a shorter mean duration 
than Group I, the difference was not significant (Table 2). 
Ureteral avulsion occurred in one patient. The operation 
stopped immediately to manage the avulsion by open sur-
gery (ureteroureteral anastomosis). The patient was ex-
amined with intravenous pyelography after a ureteral 
stent had been indwelling for 2 months. Ureteral perfo-
rations occurred in three male patients who had impacted 
stones with ureteral narrowing or kinking, because guide 
wires could not pass the obstructed ureters in these cases. 
Intraoperative ureteral perforation was managed by plac-
ing an indwelling ureteral stent after stopping the proce-
dure as soon as possible. All patients who suffered from ure-
teral perforations underwent intravenous pyelography 2 
weeks after the removal of the ureteral stent. Ureteral 
avulsion and perforation, which are types of intraoperative 
complications, occurred in 4 patients (2.8%), and the in-
cidence was 4.4% in Group I and 1.3% in Group II, respec-
tively. A higher incidence was noted in Group I, but the dif-
ference was not statistically significant (p=0.344; Table 2). 
There was no evidence of ureteral stricture or extravasation 
of contrast material in any patient with ureteral avulsion 
and perforation. In the six cases, postoperative complica-
tions including fever were rarely found, two of these six cas-
es had shown urinary tract infection. Three patients had 
reported postoperative voiding symptoms related to stents. 
All of them were cleared after stent removal. No long-term 
complications were found in any cases. There was no sig-
nificant difference in incidence between the two groups.
DISCUSSION
As incredible advances in technology have taken place dur-
ing the past decade, the method of tackling urinary tract 
stones has been notably refined. These novel therapies 
such as percutaneous stone treatment, ESWL, and ure-
teroscopy have virtually replaced open stone surgery. To 
a certain extent, ESWL is regarded as one of the most pre-
ferred treatment modalities for most upper urinary tract 
stones. Even though ESWL has been verified as a strong 
therapy, several clinical situations still have to be consid-Korean J Urol 2010;51:719-723
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FIG. 1. The NTrap
Ⓡ in its packaging (A), before pushing the inner core (B), and after pushing the inner core (C). 
ered as special indications for ureteroscopic removal of 
calculi. These clinical factors that should be taken into ac-
count are previous failure after an ESWL treatment, the 
existence of firmly impacted (large) stones, and associated 
distal obstruction [6]. Ureteroscopic stone removal is also 
a highly recommended option for those patients with bleed-
ing diathesis and those patients for whom ESWL and per-
cutaneous procedures are contraindicated [7].
Recently, ureteroscopy has emerged as the first-line pro-
cedure for increasingly challenging stone cases [8]. Kim et 
al reported that ureteroscopic removal of stones achieved 
an excellent stone-free rate and a complication rate similar 
to that of ESWL for treating large (＞10 mm) upper ureteral 
calculi [9]. Furthermore, the miniaturization of uretero-
scopes and improved intracorporeal lithotripsy technology 
has made it possible to successfully access and treat vir-
tually any stone within the ureter in a relatively atrau-
matic fashion [10].
Proximal calculus migration during ureteroscopy re-
mains a significant problem, however. Stone retropulsion 
rates for various pneumatic lithotriptors are as high as 15% 
to 48% [5,11]. Knispel et al reported 40% ureteral calculous 
migration from the proximal ureter and 5% from the distal 
ureter [12]. Both pneumatic lithotriptors and holmium:YAG 
lasers are known to cause calculus retropulsion, the former 
to a greater extent than the latter. Robert et al reported 48% 
calculous migration from the proximal ureter when pneu-
matic intracorporeal lithotripsy was done [13].
Stone retropulsion increases operative times and cost be-
cause it entails a change of the semi-rigid ureteroscope to 
a flexible instrument in order to chase the migrated stone.  
Even after the operation, additional procedures might be 
required to treat residual migrated fragments [6,14].
Stone retropulsion has also been studied in vitro. 
Marguet et al reported that at clinically relevant settings, 
the holmium:YAG laser caused less stone retropulsion 
than did the frequency doubled double pulse Nd:YAG 
(FREDDY) laser and that both of these lasers caused less 
retropulsion than the Swiss Lithoclast (EMS, Nyon, Switz-
erland) pneumatic lithotriptor [15]. However, the magni-
tude of stone retropulsion was great enough for all modal-
ities that the authors recommended using an occlusive de-
vice such as the Stone Cone during ureteroscopy in all 
cases. 
The occlusive devices represent a new generation of tech-
nology that minimize proximal ureteral stone migration. 
Several new stone retrieval and ureteral occlusive devices 
have become commercially available over the past few 
years. Bagley et al have outlined how ureteroscopy has 
evolved from 1996 to 2004 [16]. Their study showed that, 
during that time, nitinol baskets supplanted the three- 
prong grasper for removal of stones and stone fragments. 
The two novel devices (Stone Cone and NTrap
Ⓡ) have been 
previously tested and compared for pull-through strength, 
which is the force required for each device to deploy and re-
lease the beads in a strictured ureter model. Ouwenga et 
al reported statistically significant but clinically insignif-
icant differences in the releasing force of the two devices 
[17]. The Stone Cone showed a pull-through strength of 
0.190 lbf and the NTrap
Ⓡ device showed a strength of 0.861 
lbf, which the group believed was presumably too low to re-
sult in ureteral avulsion. 
In a recent paper, the Accordion
Ⓡ device was shown to 
be highly efficient and safe in vitro to prevent stone migra-
tion. A clinical trial will have to assess its value in endouro-
logical practice [18]. In Korea, Chung et al reported that 
with the use of the Stone Cone, the success rate of uretero-
scopic removal of proximal ureteral stones was 100% [19]. 
The NTrap
Ⓡ is a relatively new ureteral occlusive device 
that prevents the migration of stone fragments during ure-
teroscopic lithotripsy. The NTrap
Ⓡ is composed of a tightly 
woven mesh of nitinol wires that essentially consists of the 
inner wire and the outer radio-opaque carrying catheter. 
The inner wire is a shape memory alloy that has a 7 mm 
sized umbrella design, namely, the basket (Fig. 1). Its di-
ameter is 2.8 Fr and its total length is 145 cm. Han et al 
reported the efficacy of the NTrap
Ⓡ for the treatment of ure-
teral stones in their initial clinical experience [20]. That Korean J Urol 2010;51:719-723
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study revealed that the overall stone-free rate was 100% 
and no patient had residual fragments larger than 3 mm 
and none required additional treatment. Our study also 
demonstrated that the NTrap
Ⓡ can increase the success 
rate of stone removal, especially for stones ＞5 mm size and 
with the use of the holmium:YAG laser as the lithotriptor. 
The NTrap
Ⓡ not only blocks stone retropulsion, but is also 
effective for removal of residual fragments. 
Economic efficiency can be another strong reason for 
choosing the NTrap
Ⓡ [20]. The Ntrap
Ⓡ can save time and 
cost by lowering the rate of stone retropulsion, which invol-
ves unnecessary procedures such as prolonged operative 




Ⓡ can minimize the risk of stone retropulsion 
during ureteroscopic lithotripsy. In this study, we found 
that the use of the NTrap
Ⓡ can increase the success rate 
of stone removal, especially for stones ＞5 mm size and with 
the use of the holmium:YAG laser as the lithotriptor. As a 
result, the NTrap
Ⓡ, which is an instrument that assists 
during ureteroscopic lithotripsy, can be an effective tool to 
prevent stone retropulsion and to aid in safe stone removal. 
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